Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Bendamustine/Rituximab Induction Followed by Venetoclax/Rituximab Consolidation in Frontline Treatment of Chronic Lymphocytic Leukemia: A Phase 2 Multi-Center Study.
Journal: Hematological oncology
Published: January 06, 2026
First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level.
Journal: Haematologica
Published: October 10, 2025
Treatment-emergent coagulopathy during azacitidine/venetoclax induction in AML.
Journal: Blood neoplasia
Published: October 07, 2025
Efficacy of first-line tagraxofusp in blastic plasmacytoid dendritic cell neoplasm with prior or concomitant hematologic malignancy: subgroup analysis of a pivotal trial.
Journal: Leukemia & lymphoma
Published: March 11, 2025
Sweet Syndrome in the Central Nervous System: A Case of Orbital Inflammation, Sixth Nerve Palsy, and Pachymeningitis.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Published: September 04, 2024
Implementation of Systematic Financial Screening in an Outpatient Breast Oncology Setting.
Journal: JCO clinical cancer informatics
Published: March 21, 2023
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
Journal: Cancer discovery
Published: September 12, 2022
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 12, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 19, 2021
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial.
Journal: The Lancet. Haematology
Published: January 04, 2019
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.
Journal: Blood advances
Published: November 13, 2017
Last Updated: 09/26/2026